Printer Friendly
The Free Library
14,497,195 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Takara Bio, Chinese CDC to Collaborate in AIDS Research.


Tokyo, Japan, June 20, 2006 - (JCN) - Takara Bio announced on June 19 that it has reached an agreement with the Chinese Center for Disease Control and Prevention Noun 1. Center for Disease Control and Prevention - a federal agency in the Department of Health and Human Services; located in Atlanta; investigates and diagnoses and tries to control or prevent diseases (especially new and unusual diseases)
CDC
 (Chinese CDC See Control Data, century date change and Back Orifice.

CDC - Control Data Corporation
) to collaborate in research on Acquired Immune Deficiency Syndrome Acquired immune deficiency syndrome (AIDS)

A viral disease of humans caused by the human immunodeficiency virus (HIV), which attacks and compromises the body's immune system.
 (AIDS).

The two partners will strive to confirm the efficacy of AIDS gene therapy using RNA interference enzymes. The gene therapy is intended to destroy RNA in Human Immunodeficiency Virus human immunodeficiency virus
n.
HIV.


Human immunodeficiency virus (HIV)
A transmissible retrovirus that causes AIDS in humans.
 (HIV). Specifically, the partners will conduct validation experiments using simian T-cells and Simian Immune Deficiency Virus (SIV).

Since 1981, over 25 million people have died of AIDS. Currently, it is estimated that over 40 million people are infected with HIV, of which about 8 million people reside in Asia.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jun 21, 2006
Words:127
Previous Article:Takeda Pharmaceutical Obtains Additional Approval for Its Peptic Ulcer Agent.
Next Article:GlaxoSmithKline Immunosuppressant Imuran Now Available in Japan for Treating Crohn's Disease and Ulcerative Colitis.



Related Articles
NANOSPHERE/TAKARO BIO FORM DEVELOP/DISTRIBUTE ALLIANCE.
Takara Bio Releases High-fidelity PCR Enzyme PrimeSTAR HS DNA Polymerase.
Takara Bio Sets up New Research Division at Institute for Protein Research, Osaka University.
Takara Bio, MolMed Announce That Phase I/II Clinical Trial of HSV-TK Gene Therapy Delivers Positive Results.
Takara Bio to Provide RetroNectin to City of Hope National Medical Center for Clinical Trial of AIDS Gene Therapy.
Takara Bio Chinese Subsidiary to Expand Lines of Business, Files Chinese Clinical Trial Application.
Takara Bio to Release Two New Enzymes.
Takara Bio Confirms that Kelp-derived Fucoidan Inhibits Clot Formation.
Takara Bio Licenses FLT3 Gene Mutation Detection Method to InVivoScribe Technologies.
Takara Bio Grants Transgenomic License for LA-PCR Technology.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles